The neuropsychology of the schizo-obsessive subtype of schizophrenia: A new analysis

Psychological Medicine

Volumn 40, Issue 6, 2010, Pages 921-933

  Patel, D D ^a   Laws, K R ^a   Padhi, A ^b   Farrow, J M ^b   Mukhopadhaya, K ^b   Krishnaiah, R ^b   Fineberg, N A ^a,b  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^b QUEEN ELIZABETH II HOSPITAL   (United Kingdom)

Author keywords

Endophenotype; Frontal lobes; Obsessive compulsive; Set shifting

Indexed keywords

ADULT; AFFECT; AGED; ARTICLE; ATTENTION; COMORBIDITY; CORPUS STRIATUM; DIFFERENTIAL DIAGNOSIS; EXECUTIVE FUNCTION; FEMALE; FRONTAL LOBE; HUMAN; MALE; MIDDLE AGED; NERVE CELL NETWORK; NEUROPSYCHOLOGICAL TEST; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PERCEPTIVE DISCRIMINATION; PHYSIOLOGY; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SCHIZOPHRENIA; SEMANTICS; STATISTICS;

ADULT; AFFECT; AGED; ATTENTION; COMORBIDITY; CORPUS STRIATUM; DIAGNOSIS, DIFFERENTIAL; DIAGNOSIS, DUAL (PSYCHIATRY); DISCRIMINATION (PSYCHOLOGY); EXECUTIVE FUNCTION; FEMALE; FRONTAL LOBE; HUMANS; MALE; MIDDLE AGED; NERVE NET; NEUROPSYCHOLOGICAL TESTS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEMANTICS; YOUNG ADULT;

EID: 77952419003     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291709991255     Document Type: Article

References (96)

1. Anil AE, Turgut IT, Kabakci E, Rezaki M, Gogus A (2002). The characteristics, treatment response, safety, and concominant medication use of patients receiving clozapine treatment. European Neuropsychopharmacology 12 (Suppl.), 322.
2. Aoyama F, Iida J, Inoue M, Iwasaka H, Sakiyama S, Hata K, Kishimoto T (2000). Brain imaging in childhood-and adolescent-onset schizophrenia associated with obsessive-compulsive symptoms. Acta Psychiatrica Scandinavica (Suppl.) 102, 32-37.
3. Berman I, Kalinowski A, Berman SM, Lengua J, Green AI (1995). Obsessive and compulsive symptoms in chronic schizophrenia. Comprehensive Psychiatry 36, 6-10.
4. Berman I, Merson A, Viegner B, Losonczy MF, Pappas D, Green AI (1998). Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study. Journal of Nervous and Mental Disease 186, 150-156.
5. Bermanzohn PC, Porto L, Arlow PB, Axelrod S, Sastri G, Stronger R, Pollack S, Siris S (1997). Obsessions and delusions: separate and distinct or overlapping? CNS Spectrums 2, 58-61.
6. Bermanzohn PC, Porto L, Arlow PB, Pollack S, Stronger R, Siris SG (2000). Hierarchial diagnosis in chronic schizophrenia: a clinical study co-occurring syndromes. Schizophrenia Bulletin 26, 517-525.
7. Berrios GE (1989). Obsessive-compulsive disorder: its conceptual history in France during the 19th century. Comprehensive Psychiatry 30, 283-295.
8. Bland RC, Newman SC, Orn H (1987). Schizophrenia: lifetime comorbidity in a community sample. Acta Psychiatrica Scandinavica (Suppl.) 75, 383-391.
9. Bleuler E. (1911). The Fundamental Symptoms of Dementia Praecox or the Group of Schizophrenias. International Universities Press: New York.
10. Braw Y, Bloch Y, Mendelovich S, Ratzoni G, Gal G, Harari H, Tripto A, Levkovitz Y (2008). Cognition in young schizophrenia outpatients: Comparison of first-episode with multi-episode patients. Schizophrenia Bulletin 34, 544-554.
11. Buchanan RW, Heinrichs DW (1989). The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Research 27, 335-350.
12. Byerly M, Goodman W, Acholonu W, Bugno R, Rush AJ (2005). Obsessive compulsive symptoms in schizophrenia: frequency and clinical features. Schizophrenia Research 76, 309-316.
13. Ceaser AE, Goldberg TE, Egan MF, McMahon RP, Weinberger DR, Gold JM (2008). Set-shifting ability and schizophrenia: a marker of clinical illness or an intermediate phenotype? Biological Psychiatry 64, 782-788.
14. Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TW, Sahakian BJ (2006a). Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. American Journal of Psychiatry 163, 1282-1284.
15. Chamberlain SR, Blackwell AD, Fineberg NA, Robbins TR and Sahakian BJ (2006b). Strategy implementation in obsessive-compulsive disorder and trichotillomania Psychological Medicine 36, 91-97.
16. Chamberlain SR, Fineberg NA, Blackwell AD, Clark L, Robbins TW, Sahakian BJ (2007a). A neuropsychological comparison of obsessive-compulsive disorder and trichotillomania Neuropsychologia 45, 654-662.
17. Chamberlain SR, Fineberg NA, Menzies L, Blackwell AD, Bullmore ET, Robbins TW, Sahakian BJ (2007b). Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. American Journal of Psychiatry 164, 335-338.
18. Crino R, Slade T, Andrews G (2005). The changing prevalence and severity of obsessive-compulsive disorder criteria from DSM-III to DSM-IV. American Journal of Psychiatry 162, 876-882.
19. Downes JJ, Roberts AC, Sahakian BJ, Evenden JL, Morris RG, Robbins TW (1989). Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: Evidence for a specific attentional dysfunction. Neuropsychologia 27, 1329-1343.
20. Eisen JL, Beer DA, Pato MT, Venditto TA, Rasmussen SA (1997). Obsessive-compulsive disorder in patients with schizophrenia and schizoaffective disorder. American Journal of Psychiatry 154, 271-273.
21. Elliott R, McKenna PJ, Robbins TW, Sahakian BJ (1995). Neuropsychological evidence for frontostriatal dysfunction in schizophrenia Psychological Medicine 25, 619-630.
22. Elliott R, McKenna PJ, Robbins TW, Sahakian BJ (1998). Specific neuropsychological deficits in schizophrenic patients with preserved intellectual function. Cognitive Neuropsychiatry 3, 45-70.
23. Ertugrul A, Demir B (2005). Clozapine-induced tardive dyskinesia: a case report. Progress in Neuro-Psychopharmacology & Biological Psychiatry 29, 633-635.
24. Fabisch K, Fabisch H, Langs G, Huber HP, Zapotoczky HG (2001). Incidence of obsessive-compulsive phenomena in the course of acute schizophrenia and schizoaffective disorder. European Psychiatry 16, 336-341.
25. Fenger MM, Gade A, Adams KH, Hansen ES, Bolwig TG, Knusden GM (2005). Cognitive deficits in obsessive-compulsive disorder on tests of frontal lobe functions. Nordic Journal of Psychiatry 59, 39-44.
26. Fenton WS, McGlashan TH (1986). The prognostic significance of obsessive-compulsive symptoms in schizophrenia. American Journal of Psychiatry 143, 437-441.
27. Fineberg NA, Gale T, Sivakumaran T (2006). A review of antipsychotics in treatment resistant obsessive compulsive disorder (OCD). Journal of Psychopharmacology 20, 97-103.
28. Fineberg NA, Sharma P, Sivakumaran T, Sahakian B, Chamberlain SR (2007). Does obsessive-compulsive personality disorder belong within the obsessive-compulsive spectrum? CNS Spectrums 12, 467-482.
29. Fioravanti M, Carlone O, Vitale B, Cinti ME, Clare L (2005). A meta analysis of cognitive deficits in adults with a diagnosis of schizophrenia. Neuropsychology Review 15, 73-95.
30. Fireman B, Koran LM, Leventhal JL, Jacobson A (2001). The prevalence of clinically recognized obsessive-compulsive disorder in a large health maintenance organization. American Journal of Psychiatry 158, 1904-1910.
31. Galvez-Buccollini JA, Fiestas F, Herrera P, Vega-Dienstmaier JM, Guimas B, Mazzotti G (2004). Obsessive-compulsive symptoms in schizophrenia during treatment with clozapine and conventional antipsychotic drugs. Actas Españolas de Psiquiatria 32, 211-215.
32. Goldstein JM, Goodman JM, Seidman LJ, Kennedy DN, Makris N, Lee H, Tourville J, Cavines Jr. VS, Faraone SV, Tsuang MT (1999). Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Archives of General Psychiatry 56, 537-547.
33. Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS (1989a). The Yale-Brown obsessive compulsive scale. II. Validity. Archives of General Psychiatry 46, 1012-1016.
34. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS (1989b). The Yale-Brown obsessive-compulsive scale. I. Development, use and reliability. Archives of General Psychiatry 46, 1006-1011.
35. Guy W (1976). ECDEU Assessment Manual for Psychopharmacology (Revised). US Department of Health, Education and Welfare: Bethesda, MD.
36. Hampshire A, Owen AM (2006). Fractionating attentional control using event-related fMRI. Cerebral Cortex 16, 1279-1289.
37. Haro JM, Kamath SA, Ochoa S, Novick D, Rele K, Fargas A, Rodriguez MJ, Rele R, Orta J, Kharbeng A, Araya S, Gervin M, Alonso J, Mavreas V, Lavrentzou E, Liontos N, Gregor K, Jones PB (2003). The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatrica Scandinavica (Suppl.) 416, 16-23.
38. Hermesh H, Weizman A, Gur S, Zalsman G, Shiloh R, Zohar J, Gross-Isseroffa R (2003). Alternation learning in OCD/schizophrenia patients European Neuropsychopharmacology 13, 87-91.
39. Hill K, Mann L, Laws KR, Stephenson CME, Nimmo-Smith I, McKenna PJ (2004). Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatrica Scandinavica 110, 1-14.
40. Huppert JD, Smith TE (2005). Anxiety and schizophrenia: the interaction of subtypes of anxiety and psychotic symptoms. CNS Spectrum 10, 721-731.
41. Hutton SB, Murphy FC, Joyce EM, Rogers RD, Cuthbert I, Barnes TRE, McKenna PJ, Sahakian BJ, Robbins TW (2002). Decision making deficits in patients with first episode and chronic schizophrenia. Schizophrenia Research 55, 249-257.
42. Hutton SB, Puri BK, Duncan L-J, Robbins TW, Barnes TRE, Joyce EM (1998). Executive function in first-episode schizophrenia. Psychological Medicine 28, 463-473.
43. Hwang MY, Morgan JE, Losconzcy MF (2000). Clinical and neuropsychological profiles of obsessive-compulsive schizophrenia: a pilot study. Journal of Neuropsychiatry and Clinical Neuroscience 12, 91-94.
44. Hwang MY, Opler LA (1994). Schizophrenia with obsessive-compulsive features: assessment and treatment. Psychiatric Annals 24, 468-472.
45. Jazbec S, Pantelis C, Robbins TW, Weickert T, Weinberger DR, Goldberg MC (2007). Intra-dimensional/extra-dimensional set-shifting performance in schizophrenia: impact of distractors. Schizophrenia Research 89, 339-349.
46. Joyce EM, Hutton SB, Mutsatsa S, Gibbins H, Webb E, Paul S, Robbins TW, Barnes TRE (2002). Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London Study. British Journal of Psychiatry 181 (Suppl. 43), 38-44.
47. Karno M, Golding JM, Sorenson SB, Burnam MA (1988). The epidemiology of obsessive-compulsive disorder in five US communities. Archives of General Psychiatry 45, 1094-1099.
48. Kayahan B, Ozturk O, Veznedaroglu B, Eraslan D (2005). Obsessive compulsive symptoms in schizophrenia: prevalence and clinical correlates. Psychiatry and Clinical Neurosciences 59, 291-295.
49. Kremen WS, Hoff AL (2004). Neuro-cognitive deficits in the biological relatives of individuals with schizophrenia. In Early Clinical Intervention and Prevention in Schizophrenia (ed. W. S. Stone, S. V. Faraone, M. T. Tsuang), pp. 133-158. Totowa, NJ: Humana Press.
50. Kruger S, Braunig P, Hoffler J, Shugar G, Borner I, Langkrar J (2000). Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. Journal of Neuropsychiatry and Clinical Neuroscience 12, 16-24.
51. Laws KR (1999). A meta-analytic review of Wisconsin Card Sort studies in schizophrenia: General intellectual deficit in disguise? Cognitive Neuropsychiatry 4, 1-30.
52. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, Cohen DJ (1989). The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. Journal of the American Academic Child Adolescent Psychiatry 28, 566-573.
53. Levaux M-N, Potvin S, Sepehry AA, Sablier J, Mendrek A, Stip E (2007). Computerized assessment of cognition in schizophrenia: promises and pitfalls of CANTAB. European Psychiatry 22, 104-115.
54. Lindenmayer JP, Vakharia M, Kanofsky D (1990). Fluoxetine in chronic schizophrenia [Letter]. Journal of Psychopharmacology 10, 76.
55. Lysaker PH, Bryson GJ, Marks KA, Greig TC, Bell MD (2002). Association of obsessions and compulsions in schizophrenia with neurocognition and negative symptoms. Journal of Neuropsychiatry and Clinical Neurosciences 14, 449-453.
56. Lysaker PH, Lancaster RS, Nees M, Davis LW (2004). Patterns of obsessive compulsive symptoms and social function in schizophrenia. Psychiatry Research 125, 139-146. (Pubitemid 38299476)
57. Lysaker PH, Marks KA, Picone JJ, Rollins AL, Fastenau P, Bond GR (2000). Obsessive and compulsive symptoms in schizophrenia: Clinical and neuro-cognitive correlates. Journal of Nervous and Mental Disease 188, 78-83.
58. Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382-389.
59. Mukhopadhaya K, Krishnaiah R, Taye T, Nigam A, Bailey AJ, Sivakumaran T, Fineberg NA (2009). Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern. Journal of Psychopharmacology 23, 6-13.
60. Murphy FC, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES, Sahakian BJ (2001). Decision-making cognition in mania and depression. Psychological Medicine 31, 679-693.
61. Murphy FC, Sahakian BJ, Rubinsztein JS, Michael A, Rogers RD, Robbins TW, Paykel ES (1999). Emotional bias and inhibitory control processes in mania and depression. Psychological Medicine 29, 1307-1321.
62. Myers JK, Weissman MM, Tischler GL, Holzer III CE, Leaf PJ, Orvaschel H, Anthony JC, Boyd JH, Burke Jr. JD, Kramer M (1984). Six-month prevalence of psychiatric disorders in three communities 1980 to 1982. Archives of General Psychiatry 41, 959-967.
63. Nelson HE (1982). The National Adult Reading Test (NART). Test Manual. Windsor: NFER-Nelson.
64. Niehaus DJ, Koen L, Muller J, Laurent C, Stein DJ, Lochner C, Seedat S, Mbanga I, Deleuze JF, Mallet J, Emsley RA (2005). Obsessive compulsive disorder-prevalence in Xhosa-speaking schizophrenia patients. South African Medical Journal 95, 120-122.
65. Nielen MM, den Boer JA (2003). Neuropsychological performance of OCD patients before and after treatment with fluoxetine: evidence for persistent cognitive deficits. Psychological Medicine 33, 917-925.
66. Ohta M, Kokai M, Morita Y (2003). Features of obsessive compulsive disorder in patients primarily diagnosed with schizophrenia. Psychiatry and Clinical Neurosciences 57, 67-74.
67. Ongur D, Goff DC (2005). Obsessive-compulsive symptoms in schizophrenia: associated clinical features, cognitive function and medication status. Schizophrenia Research 75, 349-362.
68. Pantelis C, Barber FZ, Barnes TRE, Nelson HE, Owen AM, Robbins TW (1999). Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophrenia Research 37, 251-270.
69. Pantelis C, Barnes TRE, Nelson HE, Tanner S, Weatherly L, Owen A, Robbins TW (1997). Frontal-striatal cognitive deficits in patients with chronic schizophrenia. Brain 120, 1823-1843.
70. Poyurovsky M, Dorfman-Etrog P, Hermesh H, Munitz H, Tollefson GD, Weizman A (2000). Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms. International Clinical Psychopharmacology 15, 169-173.
71. Poyurovsky M, Faragian S, Pashinian A, Levi A, Viosburd A, Stryjer R, Weizman R, Fuchs C, Weizman A (2007). Neurological soft signs in schizophrenia patients with obsessive-compulsive disorder. Journal of Neuropsychiatry and Clinical Neurosciences 19, 145-150.
72. Poyurovsky M, Fuchs C, Faragian S, Kriss V, Weisman G, Pashinian A, Weizman R, Weizman A (2006). Preferential aggregation of obsessive-compulsive spectrum disorders in schizophrenia patients with obsessive-compulsive disorder. Canadian Journal of Psychiatry 51, 746-754.
73. Poyurovsky M, Fuchs C, Weizman A (1999a). Obsessive-compulsive disorder in patients with first-episode schizophrenia. American Journal of Psychiatry 156, 1998-2000.
74. Poyurovsky M, Hramenkov S, Isakov V (2001). Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatry Research 102, 49-57.
75. Poyurovsky M, Isakov V, Harmonikov S, Modai I, Rachberger B, Schneidman M, Weizman A (1999b). Fluvoxamine treatment of obsessive compulsive symptoms in schizophrenic patients: an add-on open study. International Clinical Psychopharmacology 14, 95-100.
76. Poyurovsky M, Kriss V, Weisman G, Faragian S, Kurs R, Schneidman M, Fuchs C, Weizman A, Weizman R (2003). Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: Schizophrenic and OC symptoms in schizophrenia. Journal of Clinical Psychiatry 64, 1300-1307.
77. Poyurovsky M, Weizman A, Weizman R (2004). Obsessive-compulsive disorder in schizophrenia: clinical characteristics and treatment. CNS Drugs 18, 989-1010. (Pubitemid 39612010)
78. Purcell R, Maruff P, Kyrios M, Pantelis C (1998a). Cognitive deficits in obsessive-compulsive disorder on tests of fronto-striatal function. Biological Psychiatry 43, 348-357.
79. Purcell R, Maruff P, Kyrios M, Pantelis C (1998b). Neuropsychological deficits in obsessive-compulsive disorder A comparison with unipolar depression, panic disorder and normal controls. Archives of General Psychiatry 55, 415-423.
80. Rahman S, Sahakian BJ, Hodges JR, Rogers RD, Robbins TW (1999). Specific cognitive deficits in mild frontal variant frontotemporal dementia. Brain 122, 1469-1493.
81. Rajkumar RP, Reddy YC, Kandavel T (2008). Clinical profile of 'schizo-obsessive' disorder: a comparative study. Comprehensive Psychiatry 49, 262-268.
82. Rogers RD, Everitt BJ, Baldacchino A, Blackshaw AJ, Swainson R, Wynne K, Baker NB, Hunter J, Carthy T, Booker E, London M, Deakin JFW, Sahakian BJ, Robbins TW (1999). Dissociable deficits in the decision-making cognition of chronic amphetamine abusers, opiate abusers, patients with focal damage to prefrontal cortex, and tryptophan-depleted normal volunteers: Evidence for monoaminergic mechanisms. Neuropsychopharmacology 20, 322-339.
83. Rosen I (1957). The clinical significance of obsessions in schizophrenia. Journal of Mental Science 103, 773-785.
84. Sevincok L, Akoglu A, Topaloglu B, Aslantas H (2004). Neurological soft signs in schizophrenic patients with obsessivecompulsive disorder. Psychiatry and Clinical Neurosciences 58, 274-279.
85. Shamay-Tsoory SG, Shur S, Harari H, Levkovitz Y (2007). Neuro-cognitive basis of impaired empathy in schizophrenia. Neuropsychology 21, 431-438.
86. Sheehan DV, Harnett-Sheehan K, Raj BA (1996). The measurement of disability. International Clinical Psychopharmacology 3, 89-95.
87. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59 (Suppl.) 20, 34-57.
88. Simpson GM, Angus JW (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica (Suppl.) 212, 11-19.
89. Tibbo P, Kroetsch M, Chue P, Warneke L (2000). Obsessive-compulsive disorder in schizophrenia. Journal of Psychiatry Research 34, 139-146.
90. Tyson PJ, Laws KR, Roberts KH, Mortimer AM (2004). Stability of set-shifting and planning abilities in patients with schizophrenia. Psychiatry Research 129, 229-239.
91. van den Heuvel OA, Veltman DJ, Groenewegen HJ, Cath DC, van Balkom AJ, van Hartskamp J, Barkhof F, van Dyck R (2005). Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Archives of General Psychiatry 62, 301-309.
92. Veale DM, Sahakian BJ, Owen AM, Marks IM (1996). Specific cognitive deficits in tests sensitive to frontal lobe dysfunction in obsessive-compulsive disorder. Psychological Medicine 26, 1261-1269.
93. Watkins LHA, Sahakian BJ, Robertson M, Veale DM, Rogers RD, Pickard KM, Aitken MR, Robbins TW (2005). Executive function in Tourette's syndrome and obsessive-compulsive disorder. Psychological Medicine 35, 571-582.
94. Wells A, Cartwright-Hatton S (2004). A short form of the Metacognition Questionnaire: properties of the MCQ-30. Behavior, Research and Therapy 42, 385-396.
95. Whitney KA, Fastenau PS, Evans JD, Lysaker PH (2004). Comparative neuropsychological function in obsessive-compulsive disorder and schizophrenia with and without obsessive-compulsive symptoms. Schizophrenia Research 69, 75-83.
96. Zohar J, Birkett M, Wood AJ (1993). A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group European Neuropsychopharmacology 3, 143-152.